2017International Journal of Advanced ResearchOpen access

CD160 EXPRESSION IN B CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL.).

Deena Elshabrawy, Yasmin Nabil El-Sakhawy, Eman Ismail Ibrahim, M.B.B.Ch, Msc.

Open full text 0 citations

Abstract

CLL is usually diagnosed through the charachteristic morphology/immunophenotype of the lymphocytes, but some CLL cases remain atypical resulting in uncertain diagnosis. CD160 is a glycosylphosphatidylinositol-Linked

Open-access reader

About this research paper

What this paper is about

CLL is usually diagnosed through the charachteristic morphology/immunophenotype of the lymphocytes, but some CLL cases remain atypical resulting in uncertain diagnosis. CD160 is a glycosylphosphatidylinositol-Linked

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

CLL is usually diagnosed through the charachteristic morphology/immunophenotype of the lymphocytes, but some CLL cases remain atypical resulting in uncertain diagnosis. CD160 is a glycosylphosphatidylinositol-Linked

Key concepts: Chronic lymphocytic leukemia, Leukemia, Medicine, Oncology, Internal medicine, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
CD160 EXPRESSION IN B CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL.). — Research Paper | ScholarLens